Ira E. Ritter

CIK 1631674 · COB, CSO · last filed 2022-08-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$17.5K

Companies

3

Total Filings

15

Lifetime Open-Market Net

$3.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Qualigen Therapeutics, Inc. (QLGN) Delisted	Director	—	$3.21	—	$0	2	2022-08-04
Qualigen Therapeutics, Inc. (RTTR) Delisted	COB, CSO	625	—	—	$3.0K	9	2020-05-19
WORX	Director	50,000	$0.35	$17.5K	$0	3	2019-12-16

Recent Filings · Page 2 of 2

15 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2017-10-27	Qualigen Therapeutics, Inc. (RTTR) Delisted	Buy (P)	+187,500	$0	EDGAR
2016-10-25	Qualigen Therapeutics, Inc. (RTTR) Delisted	Grant (A)	—	$0	EDGAR
2016-07-07	Qualigen Therapeutics, Inc. (RTTR) Delisted	Grant (A)	—	$0	EDGAR
2016-02-24	Qualigen Therapeutics, Inc. (RTTR) Delisted	Buy (P)	+6,250	$10.0K	EDGAR
2015-06-30	Qualigen Therapeutics, Inc. (RTTR) Delisted	Conv (C)	+817,272	$0	EDGAR

Showing 11–15 of 15

Prev Page 2 of 2

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.